Company Information

CIN
Status
Date of Incorporation
10 November 2009
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
23 September 2023
Paid Up Capital
178,332,000
Authorised Capital
180,000,000

Directors

Sarada Vijaya Kumari Kalidindi
Sarada Vijaya Kumari Kalidindi
Director/Designated Partner
over 2 years ago
Akella Satya Surya Visweswara Srinivas
Akella Satya Surya Visweswara Srinivas
Director/Designated Partner
about 8 years ago
Krishnam Raju Kalidindi
Krishnam Raju Kalidindi
Director/Designated Partner
about 9 years ago

Past Directors

Ameer Basha Paspala
Ameer Basha Paspala
Director
about 8 years ago
Mahesh Kandula
Mahesh Kandula
Whole Time Director
over 13 years ago
Gokaraju Laxman Raju
Gokaraju Laxman Raju
Director
about 16 years ago

Patents

Cysteamine And Its Analogues Are Used For The Treatment Of Cystinosis, Nash And Leigh Syndrome

Cysteamine and its derivatives, compositions, methods of synthesizing and using compounds of Formula 1 are disclosed. The compounds of Formula 1 also comprise of salts, polymorphs, solvates and hydrates thereof. The compounds may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be fo...

Penicillamine And Its Derivatives Are Used In The Treatment Of Copper Toxicity And Nash

Penicillamine and its derivatives, composition, methods of synthesizing and using the compound of formula 1 are disclosed. The compound"s of formula 1 also comprises of salts, polymorphs, solvates and hydrates thereof. The compounds may be formulated as pharmaceutical compositions. The pharmaceutical compositions ma...